← Open Payments lookup

DANIEL PARK: Open Payments

NPI 1124201801 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 38 payments from 13 companies in 2025. Trend: 2023 $839 · 2024 $100 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$280
Neurocrine BioSciences, Inc.6$146
E.R. Squibb & Sons, L.L.C.4$105
Alkermes, Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.2$49
Vanda Pharmaceuticals Inc.2$36
Sage Therapeutics, LLC2$33
Indivior Inc.1$32
ABBVIE INC.2$29
Janssen Pharmaceuticals, Inc1$19

Products named: INGREZZA, ABILIFY MAINTENA, REXULTI, COBENFY, ABILIFY ASIMTUFII, ARISTADA, TRINTELLIX, FANAPT.

Industry payments across NV — which companies pay providers there.